Previous Close | 1.0500 |
Open | 1.0100 |
Bid | 1.0800 x 1000 |
Ask | 1.1800 x 1000 |
Day's Range | 1.0100 - 1.1800 |
52 Week Range | 0.5500 - 7.7200 |
Volume | |
Avg. Volume | 552,406 |
Market Cap | 175.876M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -8.0700 |
Earnings Date | Jul 04, 2022 - Jul 12, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.99 |
Subscribe to Yahoo Finance Plus to view Fair Value for RAAS
Cloopen Group Holding Limited (NYSE: RAAS) ("Cloopen" or the "Company") today announced that it received a letter from the New York Stock Exchange (the "NYSE") dated May 31, 2022, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs") and that the applicable cure period for the Company to regain compliance expires on November 30, 2022.
Cloopen Group Holding Limited (NYSE: RAAS) ("Cloopen" or the "Company") today announced that, on May 18, 2022, it received a letter from the New York Stock Exchange (the "NYSE") notifying the Company that it is not in compliance with the NYSE's continued listing standards as a result of the Company's failure to timely file its annual report on Form 20-F for the fiscal year ended December 31, 2021 (the "2021 Annual Report"). The Company expects to file the 2021 Annual Report, upon (1) the outcome
Cloopen Group Holding Limited (NYSE: RAAS) ("Cloopen" or the "Company") today announced changes in independent directors of the Company.